The most common gynecologic problems in diabetic women

Authors: Zuzana Nižňanská;  Zuzana Kosibová;  Bianka Némethová
Authors‘ workplace: I. gynekologicko-pôrodnícka klinika LF UK a UNB, Bratislava
Published in: Forum Diab 2015; 4(2): 135-139
Category: Main Theme: Review


An analysis of specific gynecologic problems in diabetic women is done. Higher incidence of vulvovaginitis is connected with local factors and local immunity changes and diabetes compensation. Early diagnosis and treatment diminishes the risk of recidives and pelvic inflammatory diseases with negative influence for future fertility. Menstrual cycle disorders in diabetic women is of dysfunctional origin, linked to other endocrinopathy or hyperandrogenism. Contraception is important for family planning at the time of best diabetes compensation. Wide scale of contraceptives is available. Attention is pointed to a choice due to health condition and patients requirements. Early solution of gynecologic problems in diabetic women leads to fertility preservation.

Key words:
contraception – diabetes mellitus – menstrual cycle disorders – vulvovaginitis


1. Dei M, Di Maggio F, Di Paolo G et al. Vulvovaginitis in childhood. Best Pract Res Clin Obstet Gynaecol 2010; 24(2): 129–137.

2. Garden AS. Vulvovaginitis and other common childhood gynecological conditions. Arch Dis Child Educ Pract Ed 2011; 96(2): 73–78. Dostupné z DOI: <>.

3. Matysina LA, Greylands P, Gurkin YA. Vaginal microbiocenosis and cytology of prepubertal and adolescent girls: their role in health and disease. World J Pediatr 2010; 6(1): 32–37.

4. Nyirjesy P. Vaginitis in the adolescent patient. Pediatr Clin North Am 1999; 46(4): 733–735.

5. Curran J, Harward J, Sellers E et al. Severe vulvovaginitis as a presenting problem of type 2 diabetes in adolescent girls: a case series. Pediatrics 2011; 127(4): e1081-e1086. Dostupné z DOI: <–2311>.

6. Arraris DF, Dib SA. The hypothalamus-pituitary-ovary axis and type 1 diabetes mellitus: a mini review. Hum Reprod 2006; 21(2): 327–337.

7. Samara-Boustani D, Colmenares A, Elie C et al. High prevalence of hirsutism and menstrual disorders in obese adolescent girls and adolescent girls with type 1 diabetes mellitus despite different hormonal profiles. Eur J Endocrinol 2012; 166(2): 307–316

8. Endrikatt J, Hite R, Bannenmerschuld R et al. Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 microg ethinylestradiol/100 microg levonorgestrel and 20 microg ethinylestradiol/500 microg norethisterone. Contraception 2001; 64(1): 3–10.

9. Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group. The American College of Obstetricians and Gynecologists. Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol 2012; 120(4): 983–988.

10. WHO Medical Eligibility Criteria for Contraceptive Use. 4th ed. 2009. World Health Organization: 2010. ISBN 978 92 4 1563888. Dostupné z WWW: < 9789241563888_eng.pdf?ua=1>.

11. Gourdy P. Diabetes and oral contraception. Best Pract Res Clin Endocrinol Metab 2013; 27(1): 67–76.

12. Shawe J, Lawrenson R. Hormonal contraception in women with diabetes mellitus: Special considerations. Treatment Endocrinol 2003; 2(5): 321–330.

13. Ornstein RM, Fisher MM. Hormonal contraception in adolescents. Pediatr Drugs 2006; 8(1): 25–46.

14. Wiegratz I, Kuhl H. Long cycle treatment with oral contraceptives. Drugs 2004; 64(21): 2447–2462.

15. Ziaei S, Rajaei L, Faghihzadeh S et al. Comparative study and evaluation of side effects of low dose contraceptive administered by oral and vaginal way. Contraception 2002; 65(5): 329–331.

Diabetology Endocrinology Internal medicine
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.


Don‘t have an account?  Create new account